Denali Therapeutics
DNLI
#4216
Rank
HK$20.79 B
Marketcap
HK$133.17
Share price
0.06%
Change (1 day)
-12.69%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: HK$20.79 Billion

As of January 2026 Denali Therapeutics has a market cap of HK$20.79 Billion. This makes Denali Therapeutics the world's 4216th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$20.79 B1.45%
2025HK$20.49 B-10.99%
2024HK$23.02 B-0.58%
2023HK$23.16 B-21.51%
2022HK$29.51 B-30.52%
2021HK$42.47 B-45.46%
2020HK$77.86 B496.67%
2019HK$13.04 B-14.79%
2018HK$15.31 B42.46%
2017HK$10.75 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Denali Therapeutics was reported to be:

HK$20.74 Billion
by Nasdaq info icon info icon
HK$20.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novocure
NVCR
HK$12.52 B-39.75% Jersey
Novavax
NVAX
HK$9.21 B-55.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$28.62 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$2.96 B-85.75%๐Ÿ‡ฌ๐Ÿ‡ง UK